- Associated Press - Wednesday, December 15, 2010

SAN ANTONIO (AP) - In a Dec. 9 story about Novartis AG’s Reclast drug, The Associated Press erroneously described it as a twice-a-year treatment for osteoporosis. Reclast is given as an infusion once every two years for preventing osteoporosis in older women, and once a year to treat the disease.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More

Click to Hide